Founder and CEO of Shanahan Capital Ventures, LLC
Rebecca is the Founder and CEO of Shanahan Capital Ventures, LLC, a firm dedicated to providing differentiated business resources to clients in the Health Services, Managed Care, Distribution and Pharmacy channels. SCV leverages superior industry expertise, subject matter knowledge and demonstrated excellence in real world outcomes to invest, lead, advise and accelerate the strategic goals of a broad array of start-up, small-cap, and mid-cap healthcare companies, private equity firms, national and international firms. Clients of SCV have included privately held, publicly traded and tax-exempt organizations in Pharmaceutical Manufacturing, Hospitals & Integrated Delivery Systems, Physician and Pharmacy Networks, Health Plan and PBM based Services, Specialty, Compounding and Retail Pharmacy, Disease Therapy Management & Pathways Programs, Drug Distribution and Supply Chain, Revenue Cycle Management, Health Informatics and Analytics.
Mrs. Shanahan is a Past President of the National Association of Specialty Pharmacy. She was recognized as the 2017 Healthcare Entrepreneur of the Year by the Ernst and Young for the Mountain Desert Region. In 2014 she was listed as the Female CEO leading the top woman led Inc 5000 fastest growing company.
She served as CEO of Avella Specialty Pharmacy (2014-2018). Prior to her tenure at Avella she provided Executive Leadership at Cardinal Health (2011 to 2014); Shoppers Drug Mart, Inc. of Canada (2008 to 2011); OTN Holdings, Inc.(2007); Aetna Specialty Pharmacy (2005-5007); Priority Healthcare/Express Scripts (2002-2004); University of Chicago Hospitals and Health System (1997-2002); Methodist Hospital and Health Systems (1991-1996) and Community Hospitals of Indiana. She participated on a number of Boards of Directors and served as Committee Chair person for a number of Board Committees in Compliance and Audit, including Aesyntix Health; Avella Specialty Pharmacy; Manatee Wound Care; Naryx; Oncology Plus; Priority Healthcare; and Sanovia.